Roivant Sciences ROIV
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–
ROIV Stock News
Headlines matching Roivant Sciences or the ROIV ticker, most recent first.
- H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $47
- A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $46 to $55
- Bernstein Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $41
- J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41 Positive
- J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating
- Stifel Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $51
- Stifel Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $51
- TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $55
- H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41 Positive
- TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $50 Positive
- Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $42 Positive
- Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
- H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $41
- J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
- Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46 Positive
No comments yet — be the first to weigh in on ROIV.
Sign in to join the discussion.